Cassady Schiller Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Cassady Schiller Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$1.48K	Buy	+12	New	+$1.41K	﹤0.01%	670

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cassady Schiller Wealth Management's JAZZ Position: Q4 2024 in Review

Cassady Schiller Wealth Management opened a new position in Jazz Pharmaceuticals (JAZZ) in Q4 2024: 12 shares worth $1.48K. The stake represents ﹤0.01% of the portfolio and ranks #670 among its holdings.

508 funds tracked by Wall St. Rank hold JAZZ as of Q4 2024.

Cassady Schiller Wealth Management held 12 shares of Jazz Pharmaceuticals worth $1.48K as of Q4 2024.
Jazz Pharmaceuticals was a new Cassady Schiller Wealth Management position in Q4 2024.
Jazz Pharmaceuticals made up ﹤0.01% of Cassady Schiller Wealth Management's portfolio in Q4 2024, its #670 holding.
508 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2024.

Based on Cassady Schiller Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.